GSE190178 MEK CDK8 inhibition 3 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE190178_MEK_CDK8 inhibition_3_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE190178_MEK_CDK8 inhibition_3_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE190178_MEK_CDK8 inhibition_3_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE190178_MEK_CDK8 inhibition_3_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

DExD-box helicase 52

Gene

POU class 3 homeobox 3

Gene

long intergenic non-protein coding RNA 2693

Gene

HAND2 antisense RNA 1

Gene

H2B clustered histone 20, pseudogene

Gene

TPTE pseudogene 1

Gene

firre intergenic repeating RNA element

Gene

NIPBL divergent transcript

Gene

long intergenic non-protein coding RNA 1234

Gene

H2B clustered histone 19, pseudogene

  • Gene

    DExD-box helicase 52


  • Gene

    POU class 3 homeobox 3


  • Gene

    long intergenic non-protein coding RNA 2693


  • Gene

    HAND2 antisense RNA 1


  • Gene

    H2B clustered histone 20, pseudogene


  • Gene

    TPTE pseudogene 1


  • Gene

    firre intergenic repeating RNA element


  • Gene

    NIPBL divergent transcript


  • Gene

    long intergenic non-protein coding RNA 1234


  • Gene

    H2B clustered histone 19, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.